| scholarly article | Q13442814 |
| P2093 | author name string | X Yang | |
| X Shi | |||
| X Cao | |||
| S Bai | |||
| P2860 | cites work | TGF-beta signal transduction | Q22003891 |
| Two human homeobox genes, c1 and c8: structure analysis and expression in embryonic development | Q24293632 | ||
| Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes | Q24310852 | ||
| TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4 | Q24314661 | ||
| MADR1, a MAD-related protein that functions in BMP2 signaling pathways | Q24317247 | ||
| Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor | Q24321977 | ||
| Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene | Q24596458 | ||
| Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling | Q27765346 | ||
| TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
| Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells | Q28142906 | ||
| Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling | Q28142915 | ||
| The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling | Q28243202 | ||
| Smad4 and FAST-1 in the assembly of activin-responsive factor | Q28248490 | ||
| Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling | Q28251743 | ||
| Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members | Q28280195 | ||
| Transforming growth factor beta1 induces nuclear export of inhibitory Smad7 | Q28286474 | ||
| Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2 | Q28511063 | ||
| Evidence for regulation of cartilage differentiation by the homeobox gene Hoxc-8. | Q36281485 | ||
| Pattern of transcription of the homeo gene Hox-3.1 in the mouse embryo | Q36415965 | ||
| Competition for a unique response element mediates retinoic acid inhibition of vitamin D3-stimulated transcription. | Q38353899 | ||
| Smad1 domains interacting with Hoxc-8 induce osteoblast differentiation | Q40907671 | ||
| Induction of Smad6 mRNA by bone morphogenetic proteins | Q41056735 | ||
| Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. | Q41069920 | ||
| Detection of a novel cell cycle-regulated kinase activity that associates with the amino terminus of the retinoblastoma protein in G2/M phases | Q41349328 | ||
| Smad6 functions as an intracellular antagonist of some TGF-beta family members during Xenopus embryogenesis. | Q48023696 | ||
| Smad6 inhibits signalling by the TGF-beta superfamily | Q48044158 | ||
| Signal transduction by bone morphogenetic proteins | Q77163167 | ||
| Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification | Q77995318 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8267-70 | |
| P577 | publication date | 2000-03-24 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Smad6 as a transcriptional corepressor | |
| P478 | volume | 275 |
| Q53605893 | A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney. Interrelationships between growth factors that regulate EMT in the adult kidney. |
| Q40768248 | A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling |
| Q24307781 | Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium |
| Q21136351 | Bare bones pattern formation: a core regulatory network in varying geometries reproduces major features of vertebrate limb development and evolution |
| Q24299331 | Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6 |
| Q28659195 | Bone regeneration and stem cells |
| Q24337748 | Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1 |
| Q36769159 | Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors |
| Q52141299 | Dissection of inhibitory Smad proteins: both N- and C-terminal domains are necessary for full activities of Xenopus Smad6 and Smad7. |
| Q39698194 | Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma |
| Q36106667 | Elevating CLIC4 in Multiple Cell Types Reveals a TGF- Dependent Induction of a Dominant Negative Smad7 Splice Variant |
| Q37188757 | Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs |
| Q21093363 | Functional analysis of human mutations in homeodomain transcription factor PITX3 |
| Q24682784 | GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations |
| Q34439668 | Hox genes and their candidate downstream targets in the developing central nervous system |
| Q50590994 | Hox10-regulated endodermal cell migration is essential for development of the ascidian intestine. |
| Q52536468 | Human Fibrotic Diseases: Current Challenges in Fibrosis Research. |
| Q35105653 | Inhibitory SMADs: potential regulators of ovarian function |
| Q24556984 | Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis |
| Q38350475 | Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity |
| Q35542423 | Matricellular proteins in cardiac adaptation and disease |
| Q37044705 | Molecular basis for skeletal variation: insights from developmental genetic studies in mice |
| Q46658856 | Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism |
| Q35163981 | New intracellular components of bone morphogenetic protein/Smad signaling cascades |
| Q33560989 | New molecular medicine-based scar management strategies |
| Q26991938 | Non-transcriptional interactions of Hox proteins: inventory, facts, and future directions |
| Q39406800 | Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation |
| Q42175822 | Nuclear Smad7 Overexpressed in Mesenchymal Cells Acts as a Transcriptional Corepressor by Interacting with HDAC-1 and E2F to Regulate Cell Cycle |
| Q64108169 | Opposing roles and potential antagonistic mechanism between TGF-β and BMP pathways: Implications for cancer progression |
| Q42830492 | Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation |
| Q47070207 | Physical and genetic interactions link hox function with diverse transcription factors and cell signaling proteins |
| Q39026435 | Posttranslational Regulation of Smads |
| Q24301491 | Protein interactions of the transcription factor Hoxa1 |
| Q37437251 | Regulation of TGF-beta signaling by Smad7. |
| Q39029996 | Regulation of TGF-β Family Signaling by Inhibitory Smads. |
| Q37460835 | Regulation of neural specification from human embryonic stem cells by BMP and FGF. |
| Q24534131 | Repression of Smad2 and Smad3 transactivating activity by association with a novel splice variant of CCAAT-binding factor C subunit |
| Q38598542 | Role of Smad signaling in kidney disease |
| Q38207013 | Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma |
| Q28262241 | Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling |
| Q37358135 | Smad6 inhibits the transcriptional activity of Tbx6 by mediating its degradation |
| Q24305290 | Smad6 is a protein kinase X phosphorylation substrate and is required for HL-60 cell differentiation |
| Q35243103 | Smad6 is essential to limit BMP signaling during cartilage development |
| Q34563317 | Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. |
| Q34985673 | Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription |
| Q28239372 | Smad6 represses Dlx3 transcriptional activity through inhibition of DNA binding |
| Q24302554 | Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation |
| Q40351576 | Smad7 induces G0/G1 cell cycle arrest in mesenchymal cells by inhibiting the expression of G1 cyclins |
| Q36579619 | Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis |
| Q37832528 | Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling. |
| Q38926047 | Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling |
| Q40331728 | Smads oppose Hox transcriptional activities |
| Q24291000 | Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation |
| Q37705967 | TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma |
| Q34545421 | TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability |
| Q36242266 | The BMP signaling and in vivo bone formation |
| Q36294196 | The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling |
| Q38319514 | The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications |
| Q26863527 | Tracking context-specific transcription factors regulating hox activity |
| Q47878462 | Transcription factors-Intricate players of the bone morphogenetic protein signaling pathway |
| Q42247134 | Transcriptional profiling of leukocytes from rheumatoid arthritis patients before and after anti-tumor necrosis factor therapy: A comparison of anti-nuclear antibody positive and negative subsets |
| Q34438032 | Transforming growth factor-beta signal transduction in epithelial cells. |
| Q24550794 | Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3 |
| Q35026971 | Two major Smad pathways in TGF-beta superfamily signalling. |
| Q35082727 | Ubiquitin-dependent regulation of TGFbeta signaling in cancer |
| Q36717858 | Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis |
| Q38310184 | Yin Yang 1 (YY1) synergizes with Smad7 to inhibit TGF-β signaling in the nucleus. |
Search more.